Hematopoietic Stem Cell Transplantation for Immunodeficiency, Part I, An Issue of Immunology and Allergy Clinics, 1st Edition
Author :
Chaim Roifman
This issue is part one of a two-part issue involving the emerging field of stem cell transplantation for immunodeficiency disorders. Topics include: Past experience and future directions of BMT; Stem cell selection and manipulation; Advantage for BMT
...view more
This issue is part one of a two-part issue involving the emerging field of stem cell transplantation for immunodeficiency disorders. Topics include: Past experience and future directions of BMT; Stem cell selection and manipulation; Advantage for BMT at < 3months in SCID; Infections during and post transplantations (and other complications).
This issue is part one of a two-part issue involving the emerging field of stem cell transplantation for immunodeficiency disorders. Topics include: Past experience and future directions of BMT; Stem cell selection and manipulation; Advantage for BMT at < 3months in SCID; Infections during and post transplantations (and other complications).
https://www.us.elsevierhealth.com/hematopoietic-stem-cell-transplantation-for-immunodeficiency-part-i-an-issue-of-immunology-and-allergy-clinics-9781437718287.html6213Hematopoietic Stem Cell Transplantation for Immunodeficiency, Part I, An Issue of Immunology and Allergy Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437718287.jpg98.9998.99USDInStock/Medicine/Allergy/Clinics/Clinics15943887255255041This issue is part one of a two-part issue involving the emerging field of stem cell transplantation for immunodeficiency disorders. Topics include: Past experience and future directions of BMT; Stem cell selection and manipulation; Advantage for BMT at < 3months in SCID; Infections during and post transplantations (and other complications). This issue is part one of a two-part issue involving the emerging field of stem cell transplantation for immunodeficiency disorders. Topics include: Past experience and future directions of BMT; Stem cell selection and manipulation; Advantage for BMT at < 3months in SCID; Infections during and post transplantations (and other complications).00add-to-cart97814377182872011 and earlierProfessionalBy Chaim Roifman, MD, FRCPC, FCACB20101Book152w x 229hSaunders0Mar 8, 2010IN STOCK - This may take up to 5 business days to shipBy <STRONG>Chaim Roifman</STRONG>, MD, FRCPC, FCACBClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
